COIN put/call ratio hits a near-52-week high as Morgan Stanley's $120 target reshapes the bear case

Coinbase dropped another 4% on Monday to $137.83, taking its one-month loss to 25%. The put/call ratio jumped to 0.87 on November 2, 3.6 standard deviations above its 20-day mean, the highest reading in at least a year. Options traders are paying up for downside protection at the same moment the Street's most prominent new bear is setting a target 13% below the current price.

The options market reacts

The PCR of 0.87 compares with a 20-day mean of 0.79 and sits just below the 52-week high of 0.88. It has not been close to this level for any sustained period in the data window: the prior session's reading was 0.78, meaning the jump happened in a single day. That kind of step-change in put demand, arriving days after the stock fell 11.6% on earnings, points to fresh hedging rather than a gradual accumulation of bearish views.

The 52-week low on the PCR was 0.61, recorded when COIN was trading well above current levels. The distance between that low and today's reading captures how far sentiment has travelled since the October peak.

Keefe Bruyette trims but holds the line

This morning, Keefe, Bruyette & Woods analyst Stephen Glagola lowered his price target on COIN from $237 to $221 while maintaining an Outperform rating. Cantor Fitzgerald did the same on November 2, cutting from $212 to $200 but keeping Overweight. Both firms are absorbing the Q3 disappointment without abandoning their constructive view.

The divide on the Street is now sharp. Morgan Stanley's $120 Underweight target, set on November 2, ties Barclays for the most bearish position and sits 13% below Monday's close. Canaccord's $275 Buy sits 99% above it. The consensus mean is $198, a 44% premium to where the stock is trading. That gap is arithmetically large, but it reflects a bifurcated analyst community rather than uniform confidence. Twelve analysts rate COIN a Hold. Two rate it a Sell.

Peers and short positioning

COIN fell 13.6% over the past week. Its closest peers had a median decline of around 7.8% over the same period. BLSH fell 18%, GEMI dropped 7.5%, and HOOD was off 9.7%. COIN is not an outlier to the downside versus every name in the group, but it is clearly underperforming the median.

Short interest has moved the other way. At 9.8% of free float as of October 30, it is down 7.7% over the past week as bears take profits into the decline. Availability in the lending pool remains extremely loose at 511%, more than five shares available for every one currently borrowed. Cost to borrow is 0.38%, low by any measure. The borrow market is not pricing any squeeze risk.

What to watch

The next earnings date is February 11, 2027. Between now and then, the critical level to monitor is whether the PCR holds above 0.85, and whether any of the remaining Buy-rated analysts follow Morgan Stanley's lead on the rating itself rather than just trimming targets. Keefe Bruyette's maintained Outperform this morning, after the Morgan Stanley downgrade was already public, is the clearest signal that not everyone on the Street shares that view.

Data summary

• Price: $137.83, down 4.0% on the day, down 24.7% over one month
• Put/call ratio: 0.87, z-score of 3.6, 52-week high is 0.88
• Short interest: 9.8% of free float, down 7.7% week on week
• Lending availability: 511%, loose
• Cost to borrow: 0.38%
• Consensus mean target: $198 (range: $120 to $275)
• Next earnings: February 11, 2027